Study of Extracellular Matrix Changes in Liver Cancer
Author Information
Author(s): Lai Keane K. Y., Shang Sufen, Lohia Neha, Booth Garrett C., Masse Derek J., Fausto Nelson, Campbell Jean S., Beretta Laura
Primary Institution: Fred Hutchinson Cancer Research Center
Hypothesis
What are the changes in the extracellular matrix and associated receptor proteomes during the transition from liver fibrosis and steatohepatitis to hepatocellular carcinoma?
Conclusion
The study identified significant changes in extracellular matrix proteins and integrin networks associated with liver cancer, providing insights for potential diagnostic and therapeutic strategies.
Supporting Evidence
- 26 collagen-encoding genes were identified in the liver of both mouse models.
- 16 collagens were expressed at the protein level for the first time.
- Significant increases in collagen types IV, VI, VII, X, XIV, XV, XVI, and XVIII were observed in tumors.
- Integrin α5 was the most abundant integrin subunit identified in the tumors.
- Up-regulation of nidogen 1, decorin, and perlecan was noted in both models.
Takeaway
The study looked at how certain proteins in the liver change when cancer develops, helping us understand how to better diagnose and treat liver cancer.
Methodology
Mass spectrometry was used to analyze liver tissues from two mouse models at different disease stages.
Participant Demographics
Mice models (PDGFC transgenic and Pten null) were used in the study.
Statistical Information
P-Value
p=0.008
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website